Stockscreener 앱 받기
1.77
3.21%
0.055
Transcode Therapeutics Inc (RNAZ) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
61.76%
6.7895
|
17.76 | 16.03 | 4.5612 | 4.2211 |
| Operating Income/Loss |
61.76%
-6.7895
|
-17.76 | -16.03 | -4.5612 | -4.2211 |
| Nonoperating Income/Loss |
80.29%
0.0397
|
0.2013 | 2.8095 | -0.2949 | -0.0554 |
| Income/Loss From Continuing Operations Before Tax |
61.55%
-6.7498
|
-17.55 | - | -4.8561 | -4.2765 |
| Income Tax Expense/Benefit, Deferred |
99.87%
0.0003
|
0.2313 | - | - | - |
Net Income/Loss
|
62.05%
-6.7501
|
-17.79 | -13.44 | -4.8561 | -4.2765 |
| Basic Average Shares |
4.39%
0.9572
|
0.917 | - | 0.8337 | 0.8337 |
| Diluted Average Shares |
4.39%
0.9572
|
0.917 | - | 0.8337 | 0.8337 |
| Basic Earnings Per Share |
66.31%
-7.17
|
-21.28 | - | -5.82 | -5.13 |
| Diluted Earnings Per Share |
66.31%
-7.17
|
-21.28 | - | -5.82 | -5.13 |
3.09%
0.72%
자본화:
|
볼륨(24시간):